
Codexis, Inc. is classed by the SEC under Industrial Organic Chemicals (industry code 2860), based in Redwood City, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $70 million and a loss of $44 million (its filed statements).
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2860, Industrial Organic Chemicals); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
Headline 4.4 out of ten, 8 of 9 metrics filed and 1 estimated: past 4.4 out of ten, present 3.0 out of ten, future 6.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
Newest annual report: Form 10-K filed 2026-03-11 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-11 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-11 (on EDGAR). Newest filing: Form SCHEDULE 13G/A, 2026-08-13. Filings on record since 2002. Read from EDGAR 2026-10-12.
Product and service lines in fiscal 2025: Research and Development Revenue 63%, Product 37%. By geography: United States 61%, APAC 25%, India 8%, Switzerland 6%, Singapore 1%. As tagged in its annual report (Form 10-K, filed 2026-03-11).
Dilly, Stephen George (President and Chief Executive Officer); Moore, Alison (President and CEO); Erbez, Georgia (Chief Financial Officer and Chief Business Officer); Lutz, Stefan (Chief Scientific Officer); Collins, Cynthia (director); De, Vre Raymond (director); Martinborough, Esther (director); Parker, H Stewart (director); Richards, Christos (director); Singhvi, Rahul (director); and 2 more. 12 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.